Aradigm Corporation
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria

Abstract:

Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.